Constitutive activity of neural melanocortin receptors

Methods in Enzymology

Volumn 484, Issue C, 2010, Pages 267-279

  Tao, Ya Xiong ^a   Huang, Hui ^a   Wang, Zhi Qiang ^a,b   Yang, Fan ^a   Williams, Jessica N ^a   Nikiforovich, Gregory V ^c  

^a AUBURN UNIVERSITY   (United States)

^b YANGZHOU UNIVERSITY   (China)

^c MolLife Design LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGOUTI PROTEIN; AGOUTI RELATED PROTEIN; BETA 2 ADRENERGIC RECEPTOR; LIGAND; MELANOCORTIN 3 RECEPTOR; MELANOCORTIN 4 RECEPTOR; MELANOCORTIN RECEPTOR AGONIST; MUTANT PROTEIN; OPSIN; TRANSDUCIN;

ANOREXIA NERVOSA; BOOK; CELL ASSAY; CELL STRAIN HEK293; ENERGY EXPENDITURE; GENE MUTATION; GENETIC TRANSCRIPTION; HOMEOSTASIS; HUMAN; HUMAN CELL CULTURE; INVERSE AGONISM; LOSS OF FUNCTION MUTATION; MOLECULAR MODEL; NEUROBIOLOGY; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN STABILITY; PROTEIN STRUCTURE; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION; WILD TYPE;

AGOUTI;

EID: 78049311714     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-381298-8.00014-9     Document Type: Chapter

References (44)

1. Balthasar N., Dalgaard L.T., Lee C.E., Yu J., Funahashi H., Williams T., Ferreira M., Tang V., McGovern R.A., Kenny C.D., Christiansen L.M., Edelstein E., et al. Divergence of melanocortin pathways in the control of food intake and energy expenditure. Cell 2005, 123:493-505.
2. Butler A.A., Kesterson R.A., Khong K., Cullen M.J., Pelleymounter M.A., Dekoning J., Baetscher M., Cone R.D. A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. Endocrinology 2000, 141:3518-3521.
3. Calton M.A., Ersoy B.A., Zhang S., Kane J.P., Malloy M.J., Pullinger C.R., Bromberg Y., Pennacchio L.A., Dent R., McPherson R., Ahituv N., Vaisse C. Association of functionally significant melanocortin-4 but not melanocortin-3 receptor mutations with severe adult obesity in a large North American case-control study. Hum. Mol. Genet. 2009, 18:1140-1147.
4. Chai B.X., Neubig R.R., Millhauser G.L., Thompson D.A., Jackson P.J., Barsh G.S., Dickinson C.J., Li J.Y., Lai Y.M., Gantz I. Inverse agonist activity of agouti and agouti-related protein. Peptides 2003, 24:603-609.
5. Chen A.S., Marsh D.J., Trumbauer M.E., Frazier E.G., Guan X.M., Yu H., Rosenblum C.I., Vongs A., Feng Y., Cao L., Metzger J.M., Strack A.M., et al. Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat. Genet. 2000, 26:97-102.
6. Chen C., Okayama H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 1987, 7:2745-2752.
7. 2 -adrenergic G protein-coupled receptor. Science 2007, 318:1258-1265.
8. Cone R.D. Anatomy and regulation of the central melanocortin system. Nat. Neurosci. 2005, 8:571-578.
9. Cone R.D. Studies on the physiological functions of the melanocortin system. Endocr. Rev. 2006, 27:736-749.
10. Fan Z.C., Sartin J.L., Tao Y.X. Molecular cloning and pharmacological characterization of porcine melanocortin-3 receptor. J. Endocrinol. 2008, 196:139-148.
11. Fan Z.C., Sartin J.L., Tao Y.X. Pharmacological analyses of two naturally occurring porcine melanocortin-4 receptor mutations in domestic pigs. Domest. Anim. Endocrinol. 2008, 34:383-390.
12. Fan Z.C., Tao Y.X. Functional characterization and pharmacological rescue of melanocortin-4 receptor mutations identified from obese patients. J. Cell. Mol. Med. 2009, 13:3268-3282.
13. Farooqi I.S., Keogh J.M., Yeo G.S., Lank E.J., Cheetham T., O'Rahilly S. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N. Engl. J. Med. 2003, 348:1085-1095.
14. Feng N., Young S.F., Aguilera G., Puricelli E., Adler-Wailes D.C., Sebring N.G., Yanovski J.A. Co-occurrence of two partially inactivating polymorphisms of MC3R is associated with pediatric-onset obesity. Diabetes 2005, 54:2663-2667.
15. Haskell-Luevano C., Monck E.K. Agouti-related protein functions as an inverse agonist at a constitutively active brain melanocortin-4 receptor. Regul. Pept. 2001, 99:1-7.
16. Hinney A., Bettecken T., Tarnow P., Brumm H., Reichwald K., Lichtner P., Scherag A., Nguyen T.T., Schlumberger P., Rief W., Vollmert C., Illig T., et al. Prevalence, spectrum, and functional characterization of melanocortin-4 receptor gene mutations in a representative population-based sample and obese adults from Germany. J. Clin. Endocrinol. Metab. 2006, 91:1761-1769.
17. Huszar D., Lynch C.A., Fairchild-Huntress V., Dunmore J.H., Fang Q., Berkemeier L.R., Gu W., Kesterson R.A., Boston B.A., Cone R.D., Smith F.J., Campfield L.A., et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997, 88:131-141.
18. Lee Y.S., Poh L.K., Kek B.L., Loke K.Y. The role of melanocortin 3 receptor gene in childhood obesity. Diabetes 2007, 56:2622-2630.
19. Lee Y.S., Poh L.K., Loke K.Y. A novel melanocortin 3 receptor gene (MC3R) mutation associated with severe obesity. J. Clin. Endocrinol. Metab. 2002, 87:1423-1426.
20. Mencarelli M., Walker G.E., Maestrini S., Alberti L., Verti B., Brunani A., Petroni M.L., Tagliaferri M., Liuzzi A., Di Blasio A.M. Sporadic mutations in melanocortin receptor 3 in morbid obese individuals. Eur. J. Hum. Genet. 2008, 16:581-586.
21. Nijenhuis W.A., Oosterom J., Adan R.A. AgRP(83-132) acts as an inverse agonist on the human melanocortin-4 receptor. Mol. Endocrinol. 2001, 15:164-171.
22. Nikiforovich G.V., Baranski T.J. Structural modeling of CA mutants of GPCRs: C5a receptor. Methods Enzymol. 2010, 484:267-279.
23. Poitout L., Brault V., Sackur C., Bernetiere S., Camara J., Plas P., Roubert P. Identification of a novel series of benzimidazoles as potent and selective antagonists of the human melanocortin-4 receptor. Bioorg. Med. Chem. Lett. 2007, 17:4464-4470.
24. Proneth B., Xiang Z., Pogozheva I.D., Litherland S.A., Gorbatyuk O.S., Shaw A.M., Millard W.J., Mosberg H.I., Haskell-Luevano C. Molecular mechanism of the constitutive activation of the L250Q human melanocortin-4 receptor polymorphism. Chem. Biol. Drug Des. 2006, 67:215-229.
25. Rong R., Tao Y.X., Cheung B.M., Xu A., Cheung G.C., Lam K.S. Identification and functional characterization of three novel human melanocortin-4 receptor gene variants in an obese Chinese population. Clin. Endocrinol. 2006, 65:198-205.
26. Roth C.L., Ludwig M., Woelfle J., Fan Z.C., Brumm H., Biebermann H., Tao Y.X. A novel melanocortin-4 receptor gene mutation in a female patient with severe childhood obesity. Endocrine 2009, 36:52-59.
27. Scheerer P., Park J.H., Hildebrand P.W., Kim Y.J., Krauss N., Choe H.W., Hofmann K.P., Ernst O.P. Crystal structure of opsin in its G-protein-interacting conformation. Nature 2008, 455:497-502.
28. Srinivasan S., Lubrano-Berthelier C., Govaerts C., Picard F., Santiago P., Conklin B.R., Vaisse C. Constitutive activity of the melanocortin-4 receptor is maintained by its N-terminal domain and plays a role in energy homeostasis in humans. J. Clin. Invest. 2004, 114:1158-1164.
29. Steiner A.L., Kipnis D.M., Utiger R., Parker C. Radioimmunoassay for the measurement of adenosine 3',5'-cyclic phosphate. Proc. Natl. Acad. Sci. USA 1969, 64:367-373.
30. Tao Y.X. Molecular mechanisms of the neural melanocortin receptor dysfunction in severe early onset obesity. Mol. Cell. Endocrinol. 2005, 239:1-14.
31. Tao Y.X. Functional characterization of novel melanocortin-3 receptor mutations identified from obese subjects. Biochim. Biophys. Acta 2007, 1772:1167-1174.
32. Tao Y.X. Constitutive activation of G protein-coupled receptors and diseases: Insights into mechanism of activation and therapeutics. Pharmacol. Ther. 2008, 120:129-148.
33. Tao Y.X. Mutations in melanocortin-4 receptor and human obesity. Prog. Mol. Biol. Transl. Sci. 2009, 88:173-204.
34. Tao Y.X. The melanocortin-4 receptor: Physiology, pharmacology, and pathophysiology. Endocr. Rev. 2010, 31:506-543.
35. Tao Y.X., Abell A.N., Liu X., Nakamura K., Segaloff D.L. Constitutive activation of G protein-coupled receptors as a result of selective substitution of a conserved leucine residue in transmembrane helix III. Mol. Endocrinol. 2000, 14:1272-1282.
36. Tao Y.X., Segaloff D.L. Functional characterization of melanocortin-4 receptor mutations associated with childhood obesity. Endocrinology 2003, 144:4544-4551.
37. Tao Y.X., Segaloff D.L. Functional characterization of melanocortin-3 receptor variants identify a loss-of-function mutation involving an amino acid critical for G protein-coupled receptor activation. J. Clin. Endocrinol. Metab. 2004, 89:3936-3942.
38. Tao Y.X., Segaloff D.L. Functional analyses of melanocortin-4 receptor mutations identified from patients with binge eating disorder and nonobese or obese subjects. J. Clin. Endocrinol. Metab. 2005, 90:5632-5638.
39. Vaisse C., Clement K., Guy-Grand B., Froguel P. A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat. Genet. 1998, 20:113-114.
40. Vaisse C., Clement K., Durand E., Hercberg S., Guy-Grand B., Froguel P. Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J. Clin. Invest. 2000, 106:253-262.
41. Vos T.J., Caracoti A., Che J.L., Dai M., Farrer C.A., Forsyth N.E., Drabic S.V., Horlick R.A., Lamppu D., Yowe D.L., Balani S., Li P., et al. Identification of 2-[2-[2-(5-bromo-2-methoxyphenyl)-ethyl]-3-fluorophenyl]-4,5-dihydro-1H-imidazole (ML00253764), a small molecule melanocortin 4 receptor antagonist that effectively reduces tumor-induced weight loss in a mouse model. J. Med. Chem. 2004, 47:1602-1604.
42. Wang S.X., Tao Y.X. The functions of DPLIY motif and helix 8 in human melanocortin-3 receptor. Diabetes 2010, 59(Suppl):A531-A532. (Abstract 2031-P).
43. Xiang Z., Litherland S.A., Sorensen N.B., Proneth B., Wood M.S., Shaw A.M., Millard W.J., Haskell-Luevano C. Pharmacological characterization of 40 human melanocortin-4 receptor polymorphisms with the endogenous proopiomelanocortin-derived agonists and the agouti-related protein (AGRP) antagonist. Biochemistry 2006, 45:7277-7288.
44. Yeo G.S., Farooqi I.S., Aminian S., Halsall D.J., Stanhope R.G., O'Rahilly S. A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat. Genet. 1998, 20:111-112.